FSMEX — Select Medical Technology and Devices Portfolio
Data updated: 2026-07-24
FSMEX — Select Medical Technology and Devices Portfolio. Holdings, fees, performance and SEC filings.
FSMEX Fund Overview
FSMEX — Select Medical Technology and Devices Portfolio is a US mutual fund managed by Fidelity Select Portfolios, categorised as United States Large Cap Blend / Core Information Technology Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Fidelity Select Portfolios
- Category: United States Large Cap Blend / Core Information Technology Equity
- Assets under management: $2.98B
- 1-year return: -10.2%
- Ticker: FSMEX
- SEC CIK: 0000320351
- SEC series ID: S000007473
- Share class ID: C000020447
FSMEX Holdings
Top 10 holdings of Select Medical Technology and Devices Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Danaher Corp. | 15.09% |
| Thermo Fisher Scientific, Inc. | 14.06% |
| Intuitive Surgical, Inc. | 7.45% |
| Boston Scientific Corp. | 5.11% |
| Edwards Lifesciences Corp. | 4.21% |
| Stryker Corp. | 4.18% |
| Abbott Laboratories | 3.85% |
| Waters Corp. | 3.27% |
| Agilent Technologies, Inc. | 3.21% |
| West Pharmaceutical Svcs, Inc. | 3.09% |
FSMEX Portfolio Allocation
Asset-class allocation of Select Medical Technology and Devices Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.5% |
| Cash & Equivalents | 3.4% |
FSMEX Performance
Total returns for FSMEX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -15.8% |
| 1 year | -10.2% |
| 3 years (annualised) | -1.2% |
| 5 years (annualised) | -3.2% |
FSMEX Risk Information
Risk metrics for FSMEX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 15.1%
FSMEX Costs and Fees
FSMEX costs about $62 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.62%
- Gross expense ratio: 0.62%
- Portfolio turnover: 54%
- Brokerage commissions: 2.20 bps of average net assets (SEC N-CEN)
FSMEX Cashflows
Over the 12 months to 2026-05, Select Medical Technology and Devices Portfolio had net outflows of $530.29M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-05 | −$112.31M |
| 2026-04 | $261.14M |
| 2026-03 | −$66.94M |
| 2026-02 | −$83.67M |
| 2026-01 | −$91.36M |
| 2025-12 | $93.72M |
FSMEX Debt Constituents
Largest debt holdings of Select Medical Technology and Devices Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Galvanize Therapeutics | 0.03% |
FSMEX Prospectus and SEC Filings
Official Select Medical Technology and Devices Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-24
- Prospectus (485BPOS) — filed 2025-04-24
- Prospectus (485BPOS) — filed 2024-04-24
- Portfolio holdings (N-PORT) — filed 2026-07-24
- Portfolio holdings (N-PORT) — filed 2026-04-24
- Portfolio holdings (N-PORT) — filed 2026-01-23
- Annual census (N-CEN) — filed 2026-05-12
- Annual census (N-CEN) — filed 2025-05-13
Related Funds
Other United States Large Cap Blend / Core Information Technology Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.